I was diagnosed with acute myeloid leukemia (AML) when I was 18 years old the summer before I was supposed to start college. Instead, I spent six months receiving treatment on a clinical trial at CHOP. I was fortunate to have access to outstanding, cutting-edge cancer care and have a good outcome. This experience inspired me to pursue a career in medicine. I’m now a physician-scientist finishing my oncology fellowship at Dana-Farber Cancer Institution. I’m passionate about advancing the field of oncology through research and advocacy.
Robert
acute myeloid leukemia (AML)
